National Advertising Division Recommends Telecom Business Solutions Modify its AI-Pro Advertising to Avoid Confusion with ChatGPT and OpenAI
New York, NY – June 11, 2024 – BBB National Programs’ National Advertising Division recommended, as part of its routine monitoring program, that Telecom Business Solutions, Inc. d/b/a AI-Pro.org, modify its AI-Pro advertising, which uses the terms “ChatGPT” and “GPT4,” to avoid confusion about the nature of AI-Pro’s products and services and its relationship with OpenAI.
AI-Pro is not OpenAI but utilizes OpenAI's ChatGPT 3.5 and ChatGPT 4.0 technology through application programming interfaces (APIs). By integrating OpenAI's technology into some of AI-Pro’s applications, AI-Pro provides users access to OpenAI's ChatGPT.
During the proceeding, AI-Pro agreed to voluntarily modify the challenged express claims. NAD determined that AI-Pro’s modified claim “Powered by OpenAI,” “Powered by ChatGPT Technology,” accompanied by the disclosure “Independently developed and not affiliated, endorsed, or sponsored by OpenAI” makes clear that AI-Pro uses ChatGPT technology in its product offerings and is not ChatGPT.
However, NAD found that in contexts without the disclosure, or in which the disclosures are not clear and conspicuous, consumers can reasonably take away the message that AI-Pro’s product or service is ChatGPT or is affiliated with OpenAI.
Therefore, NAD recommended that:
- The disclosure “AI-PRO is Powered by OpenAI. We are not affiliated nor related to OpenAI” be clear and conspicuous, or
- That the advertising otherwise make clear that AI-Pro provides applications built on OpenAI and ChatGPT and that its APIs are not the same as or provided by OpenAI or ChatGPT.
In its advertiser statement, Telecom Business Solutions stated that it agrees to comply with NAD’s recommendations and noted that “while it has made some modifications, it will make additional ones in accordance with the NAD decision.”
All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB procedures, this release shall not be used for advertising or promotional purposes.
Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.
Latest Decisions
National Advertising Division Recommends Dr. Luke Healthcare Discontinue Treatment Claims for its Fungal Nail Renewal Product
New York, NY – July 24, 2024 – The National Advertising Division recommended Dr. Luke Healthcare discontinue certain claims for Dr. Luke’s Fungal Nail Renewal product, including health-related claims, natural claims, and claims that a doctor recommends the product or that it treats a medical condition.
National Advertising Division Finds Flag Image on Kendamil Infant Formula Packaging Conveys Supported Message about Products’ Origin
New York, NY – July 17, 2024 – In a Fast-Track SWIFT challenge, the National Advertising Division determined that use of a flag image on product packaging for Kendal Nutricare’s Kendamil infant formula reasonably conveys a supported message about the products’ origin.
In National Advertising Division Case, GuruNanda Voluntarily Discontinues Claims Made through Influencers for Coconut Pulling Oil Products
New York, NY – July 16, 2024 – The National Advertising Division has closed a Fast-Track SWIFT challenge regarding claims that GuruNanda’s coconut pulling oil products can “naturally reverse a cavity” and “reverse cavities.”
National Advertising Division Refers Health-Related Advertising Claims for Prolacta’s Human Milk Fortifier to Regulatory Agencies
New York, NY – July 15, 2024 – The National Advertising Division will refer advertising claims made by Prolacta Bioscience for its Human Milk Fortifier to the Federal Trade Commission (FTC) and Food and Drug Administration (FDA) for review.